evertex fabrinology limited

TWSE:1470 Voorraadrapport

Marktkapitalisatie: NT$1.8b

evertex fabrinology Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

evertex fabrinology heeft een totaal eigen vermogen van NT$1.0B en een totale schuld van NT$30.0M, wat de schuld-eigenvermogensverhouding op 3% brengt. De totale activa en totale passiva bedragen respectievelijk NT$1.2B en NT$176.6M. De EBIT evertex fabrinology is NT$61.6M waardoor de rentedekking -4.5 is. Het heeft contanten en kortetermijnbeleggingen van NT$386.9M.

Belangrijke informatie

3.0%

Verhouding schuld/eigen vermogen

NT$30.00m

Schuld

Rente dekkingsratio-4.5x
ContantNT$386.90m
AandelenNT$1.00b
Totaal verplichtingenNT$176.60m
Totaal activaNT$1.18b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

Nov 19
Investors Shouldn't Be Too Comfortable With evertex fabrinology's (TWSE:1470) Earnings

evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

Sep 16
evertex fabrinology limited's (TWSE:1470) Business Is Yet to Catch Up With Its Share Price

evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Mar 20
evertex fabrinology's (TWSE:1470) Profits May Not Reveal Underlying Issues

Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Apr 25
Does evertex fabrinology limited (TPE:1470) Have A Place In Your Dividend Stock Portfolio?

Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

Mar 26
Be Wary Of evertex fabrinology (TPE:1470) And Its Returns On Capital

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Mar 05
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Feb 12
Does evertex fabrinology's (TPE:1470) Statutory Profit Adequately Reflect Its Underlying Profit?

Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Jan 25
Tread With Caution Around evertex fabrinology limited's (TPE:1470) 4.6% Dividend Yield

Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Jan 07
Would Shareholders Who Purchased evertex fabrinology's (TPE:1470) Stock Year Be Happy With The Share price Today?

Is evertex fabrinology (TPE:1470) Headed For Trouble?

Dec 20
Is evertex fabrinology (TPE:1470) Headed For Trouble?

evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Dec 02
evertex fabrinology limited's (TPE:1470) Financial Prospects Don't Look Very Positive: Could It Mean A Stock Price Drop In The Future?

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( NT$649.4M ) 1470 } overtreffen de korte termijn passiva ( NT$167.3M ).

Langlopende schulden: De kortetermijnactiva 1470 ( NT$649.4M ) overtreffen de langetermijnschulden ( NT$9.3M ).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 1470 heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van 1470 is de afgelopen 5 jaar gedaald van 4.1% naar 3%.

Schuldendekking: De schuld van 1470 wordt goed gedekt door de operationele kasstroom ( 236.7% ).

Rentedekking: 1470 verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.

Balans

Ontdek gezonde bedrijven

7D

1Y

7D

1Y

7D

1Y